Using a blood or tissue biomarker to improve diagnosis and identification of a new targeted treatment.
Topical LSD1 inhibition can treat skin diseases that include cutaneous squamous cell carcinoma (cSCC), actinic keratoses, and viral warts.
A hydrogel that can naturally stretch and self-heal while adhering to the body, enabling new designs for medical adhesives.